Sign up to save your podcasts
Or
Share Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000593?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2525 ratings
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000593?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
136 Listeners
AFP: American Family Physician Podcast
696 Listeners
JAMA Clinical Reviews
497 Listeners
JACC This Week
169 Listeners
Diabetes Core Update
105 Listeners
This Week in Cardiology
883 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
296 Listeners
Frankly Speaking About Family Medicine
260 Listeners
The Curbsiders Internal Medicine Podcast
3,349 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Annals On Call Podcast
194 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Freely Filtered, a NephJC Podcast
171 Listeners
Medicine and the Machine
60 Listeners
Keeping Current
9 Listeners
Cardionerds: A Cardiology Podcast
427 Listeners